| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120586 | Journal of Clinical Virology | 2014 | 6 Pages |
Abstract
Saliva rt-PCR assay is a feasible and effective means of universal neonatal CMV screening that can detect affected infants who might benefit from treatment and follow-up. The long-term clinical significance of screening and its cost effectiveness are yet to be determined.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Galia Barkai, Daphne Ari-Even Roth, Asher Barzilai, Michal Tepperberg-Oikawa, Ella Mendelson, Minka Hildesheimer, Jacob Kuint,